Killodox 100 Dry Syrup contains Cefpodoxime Proxetil 100mg/5ml, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections such as bronchitis, pneumonia, and pharyngitis; urinary tract infections; skin and soft tissue infections; and otitis media caused by susceptible strains of bacteria. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exerting a bactericidal effect. The dry syrup formulation is particularly suitable for pediatric patients and those with swallowing difficulties, ensuring accurate dosing and improved compliance. Prior to administration, the dry powder should be reconstituted with the specified amount of water to form a suspension. Dosage and duration of therapy should be guided by the severity and type of infection, as well as patient-specific factors such as age and renal function. Common adverse effects may include gastrointestinal disturbances like diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, necessitate immediate discontinuation and medical attention. Killodox 100 Dry Syrup should be used under medical supervision, with adherence to prescribed dosing to minimize resistance development and ensure therapeutic efficacy.